IRIS Accounts Production v26.1.10.61 15136021 director 1.10.24 30.9.25 30.9.25 0 0 false true false false true false Ordinary 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 15136021 2024-09-30 15136021 2025-09-30 15136021 2024-10-01 2025-09-30 15136021 2023-09-12 15136021 2023-09-13 2024-09-30 15136021 2024-09-30 15136021 ns15:EnglandWales 2024-10-01 2025-09-30 15136021 ns14:PoundSterling 2024-10-01 2025-09-30 15136021 ns10:Director1 2024-10-01 2025-09-30 15136021 ns10:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 15136021 ns10:SmallEntities 2024-10-01 2025-09-30 15136021 ns10:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 15136021 ns10:SmallCompaniesRegimeForDirectorsReport 2024-10-01 2025-09-30 15136021 ns10:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 15136021 ns10:FullAccounts 2024-10-01 2025-09-30 15136021 ns10:OrdinaryShareClass1 2024-10-01 2025-09-30 15136021 ns10:CompanySecretary1 2024-10-01 2025-09-30 15136021 ns10:RegisteredOffice 2024-10-01 2025-09-30 15136021 ns5:CurrentFinancialInstruments 2025-09-30 15136021 ns5:CurrentFinancialInstruments 2024-09-30 15136021 ns5:ShareCapital 2025-09-30 15136021 ns5:ShareCapital 2024-09-30 15136021 ns5:RetainedEarningsAccumulatedLosses 2025-09-30 15136021 ns5:RetainedEarningsAccumulatedLosses 2024-09-30 15136021 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-09-30 15136021 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-09-30 15136021 ns10:OrdinaryShareClass1 2025-09-30 15136021 ns10:Director1 1 2024-09-30 15136021 ns10:Director1 1 2023-09-12 15136021 ns10:Director1 1 2024-10-01 2025-09-30 15136021 ns10:Director1 1 2023-09-13 2024-09-30 15136021 ns10:Director1 1 2025-09-30 15136021 ns10:Director1 1 2024-09-30

REGISTERED NUMBER: 15136021 (England and Wales)

| VJ Medical Limited |

| Financial Statements |

| for the Year Ended 30 September 2025 |

VJ Medical Limited (Registered number: 15136021)

Contents of the Financial Statements

for the year ended 30 September 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 4 |

VJ Medical Limited

Company Information

for the year ended 30 September 2025

| DIRECTOR: | Ms L Jones

| SECRETARY: | Mrs J Jones

| REGISTERED OFFICE: | 33 George Street

| Wakefield

| West Yorkshire

| WF1 1LX

| REGISTERED NUMBER: | 15136021 (England and Wales)

| ACCOUNTANTS: | SMH Jolliffe Cork Ltd

| Accountants & Business Advisors

| 33 George Street

| Wakefield

| West Yorkshire

| WF1 1LX

VJ Medical Limited (Registered number: 15136021)

Balance Sheet

30 September 2025

30.9.25 | 30.9.24 |

| Notes | £ | £

CURRENT ASSETS

Debtors | 4 | 4,361 |  | 1,464 |  |

Cash at bank | 446 |  | 5,054 |  |

4,807 |  | 6,518 |  |

CREDITORS

Amounts falling due within one year | 5 | 4,442 |  | 5,665 |  |

NET CURRENT ASSETS | 365 |  | 853 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 365 |  | 853 |  |

VJ Medical Limited (Registered number: 15136021)

Balance Sheet - continued

30 September 2025

30.9.25 | 30.9.24 |

| Notes | £ | £

CAPITAL AND RESERVES

Called up share capital | 6 | 100 |  | 100 |  |

Retained earnings | 265 |  | 753 |  |

SHAREHOLDERS' FUNDS | 365 |  | 853 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 June 2026 and were signed by:

Ms L Jones - Director

VJ Medical Limited (Registered number: 15136021)

Notes to the Financial Statements

for the year ended 30 September 2025

1. | STATUTORY INFORMATION

| VJ Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Financial instruments

| The company has chosen to adopt Sections 11 and 12 of FRS 102 in respect of financial instruments.

| All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

| Financial assets and liabilities are only offset in the balance sheet when and only when there exists a legally enforceable right to set off the recognised amounts and the company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

| Financial assets are derecognised when and only when; a) the contractual rights to the cash flows from the financial asset expire or are settled, b) the company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or, c) the company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

| Financial liabilities are derecognised only when the obligation specified in the contract is discharged, cancelled or expires.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

VJ Medical Limited (Registered number: 15136021)

Notes to the Financial Statements - continued

for the year ended 30 September 2025

2. | ACCOUNTING POLICIES - continued

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was NIL (2024 - NIL).

4. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

30.9.25 | 30.9.24 |

| £ | £

| Other debtors | 767 |  | - |  |

| Directors' current accounts | 2,273 |  | - |  |

| Prepayments | 1,321 |  | 1,464 |  |

4,361 |  | 1,464 |  |

5. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

30.9.25 | 30.9.24 |

| £ | £

| Tax | 2,588 |  | 2,596 |  |

| Directors' current accounts | - |  | 1,275 |  |

| Accrued expenses | 1,854 |  | 1,794 |  |

4,442 |  | 5,665 |  |

6. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 30.9.25 | 30.9.24 |

value: |  | £ | £

| 100 | Ordinary | £1 | 100 |  | 100 |  |

VJ Medical Limited (Registered number: 15136021)

Notes to the Financial Statements - continued

for the year ended 30 September 2025

7. | DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

| The following advances and credits to a director subsisted during the year ended 30 September 2025 and the period ended 30 September 2024:

30.9.25 | 30.9.24 |

| £ | £

| Ms L Jones

| Balance outstanding at start of year | - |  | - |  |

| Amounts advanced | 12,529 |  | - |  |

| Amounts repaid | (10,256 | ) | - |  |

| Amounts written off | - |  | - |  |

| Amounts waived | - |  | - |  |

| Balance outstanding at end of year | 2,273 |  | - |  |

8. | RELATED PARTY DISCLOSURES

| During the year, total dividends of £8,250 (2024 - £10,000) were paid to the director .